Testing version — LOERadar is in active testing. Features and data may change.
ALOGLIPTIN (ALOGLIPTIN BENZOATE) | LOERadar
Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
ALOGLIPTIN
ANDATentative Approval
ALOGLIPTIN BENZOATE | A210213 | MSN LABS PVT LTD
Products (3)
Sort:
#001 — EQ 6.25MG BASE
▴
TABLET;ORAL | TA Date: 2019-01-29 00:00:00
No patent or exclusivity listings for this strength.